Clinicopathologic characteristics | Case | JAK2 | χ2 | P | STAT3 | χ2 | P | VEGF | χ2 | P | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Positive | Negative | Positive | Negative | Positive | Negative | ||||||||
Gender | |||||||||||||
 Male | 62 | 38 | 24 | 0.295 | 0.587 | 44 | 18 | 0.220 | 0.639 | 44 | 18 | 5.459 | 0.622 |
 Female | 41 | 24 | 17 |  |  | 29 | 12 |  |  | 37 | 4 |  |  |
Age (year) | |||||||||||||
 < 50 | 47 | 32 | 15 | 0.274 | 0.600 | 34 | 13 | 1.862 | 0.172 | 36 | 11 | 1.026 | 0.311 |
 ≥ 50 | 56 | 30 | 26 |  |  | 39 | 17 |  |  | 45 | 11 |  |  |
T stage | |||||||||||||
 T1-2 | 22 | 12 | 10 | 0.373 | 0.042 | 11 | 11 | 3.311 | 0.015 | 15 | 7 | 1.822 | 0.002 |
 T3-4 | 81 | 50 | 31 |  |  | 62 | 19 |  |  | 66 | 15 |  |  |
LNM | |||||||||||||
 Yes | 60 | 41 | 19 | 3.974 | 0.046 | 48 | 12 | 0.421 | 0.016 | 51 | 9 | 3.460 | 0.043 |
 No | 43 | 21 | 22 |  |  | 25 | 18 |  |  | 30 | 13 |  |  |
N stage | |||||||||||||
 N0 | 28 | 13 | 15 | 0.704 | 0.015 | 25 | 3 | 0.317 | 0.033 | 26 | 2 | 4.627 | 0.031 |
 N1-3 | 75 | 49 | 26 |  |  | 48 | 27 |  |  | 55 | 20 |  |  |
Differentiation type | |||||||||||||
 Differentiated | 72 | 46 | 26 | 1.363 | 0.243 | 50 | 22 | 0.211 | 0.646 | 56 | 16 | 0.039 | 0.843 |
 Undifferentiated | 31 | 16 | 15 |  |  | 23 | 8 |  |  | 25 | 6 |  |  |
Clinical stage | |||||||||||||
 I–II | 48 | 22 | 26 | 5.655 | 0.017 | 29 | 19 | 0.771 | 0.038 | 29 | 19 | 13.942 | <0.001 |
 III–IV | 55 | 40 | 15 |  |  | 44 | 11 |  |  | 52 | 3 |  |  |
Smoking history | |||||||||||||
 Yes | 32 | 23 | 9 | 0.571 | 0.450 | 25 | 7 | 4.099 | 0.053 | 27 | 5 | 0.909 | 0.340 |
 No | 71 | 39 | 32 |  |  | 48 | 23 |  |  | 54 | 17 |  |  |
Family history | |||||||||||||
 Yes | 19 | 11 | 8 | 0.051 | 0.821 | 13 | 6 | 0.672 | 0.412 | 14 | 5 | 1.449 | 0.229 |
 No | 84 | 51 | 33 |  |  | 60 | 24 |  |  | 67 | 17 |  |  |